<DOC>
	<DOC>NCT00452426</DOC>
	<brief_summary>Patients routinely receive sedation during a colonoscopy or upper endoscopy (esophagogastroduodenoscopy; EGD) procedure. Propofol is a sedative that can be used during these procedures. The purpose of this study is to determine if this CAPS device enables a physician/registered nurse (RN) team to safely and effectively administer propofol sedation during colonoscopy or EGD procedures relative to current sedation practices.</brief_summary>
	<brief_title>Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>≥ 18 years old Able to comprehend, sign, and date the written informed consent form English as primary language Undergoing a nonemergent EGD or colonoscopy Have taken nothing by mouth for a minimum of 6 hours prior to the study procedure American Society of Anesthesiologists (ASA) Class I, II or III Allergy or inability to tolerate study medications or components of study medications Investigator anticipates greater than 45 minute procedure time due to known anatomical difficulty Currently using a fentanyl patch History of diagnosed sleep apnea History of diagnosed gastroparesis Baseline oxygen saturation &lt; 90% (room air) Pregnant or nursing females Body mass index (BMI) ≥ 35 Participation in a clinical trial within the past 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Propofol</keyword>
	<keyword>Diprivan</keyword>
	<keyword>Colonoscopy</keyword>
	<keyword>Endoscopy, Digestive System</keyword>
	<keyword>Conscious Sedation</keyword>
</DOC>